{
  "actions": [
    {
      "acted_at": "2020-02-11", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2020-02-11", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s3271-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "B001230", 
      "district": null, 
      "name": "Baldwin, Tammy", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-02-11", 
      "state": "WI", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S001181", 
      "district": null, 
      "name": "Shaheen, Jeanne", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-02-11", 
      "state": "NH", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2020-02-11", 
  "number": "3271", 
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4712-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Fairness in Orphan Drug Exclusivity Act", 
  "sponsor": {
    "bioguide_id": "C001075", 
    "district": null, 
    "name": "Cassidy, Bill", 
    "state": "LA", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2020-02-11", 
  "subjects": [
    "Competition and antitrust", 
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Licensing and registrations", 
    "Marketing and advertising", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Fairness in Orphan Drug Exclusivity Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Fairness in Orphan Drug Exclusivity Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Fairness in Orphan Drug Exclusivity Act", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2020-08-17T21:00:11Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s3271.xml"
}